You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKesson
Harvard Business School
Dow
Moodys

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Drug Price Trends for DIFLUNISAL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for DIFLUNISAL

Average Pharmacy Cost for DIFLUNISAL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
DIFLUNISAL 500 MG TABLET 00093-0755-06 1.34030 EACH 2020-07-22
DIFLUNISAL 500 MG TABLET 00093-0755-01 1.34030 EACH 2020-07-22
DIFLUNISAL 500 MG TABLET 14539-0673-01 1.34030 EACH 2020-07-22
DIFLUNISAL 500 MG TABLET 00093-0755-05 1.34030 EACH 2020-07-22
DIFLUNISAL 500 MG TABLET 14539-0673-06 1.34030 EACH 2020-07-22
DIFLUNISAL 500 MG TABLET 00093-0755-01 1.10749 EACH 2020-06-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or Start Trial

Best Wholesale Price for DIFLUNISAL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DIFLUNISAL 500MG TAB Teva Pharmaceuticals USA, Inc. 00093-0755-06 60 60.30 1.00500 EACH 2017-08-15 - 2022-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Boehringer Ingelheim
Mallinckrodt
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group